Target Health is pleased to announce the appointment of Mark L. Horn, MD, MPH as Sr. Medical Director. Dr. Horn is a Board Certified Rheumatologist with over 20 years of experience in the Pharmaceutical Industry. At Pfizer, Inc., Mark oversaw development programs in multiple clinical disciplines, among them arthritis & inflammation, as well as cardiovascular, neurologic, and infectious diseases. In addition, he led teams in Licensing & Development and Medical Marketing. Most recently, Mark was leader of the Worldwide Medical Policy and Evidence Based Medicine/Health Technology Assessment Teams. These groups were responsible for analyzing trends and crafting strategies to address the increasingly complex, cost driven global requirements for clinical and economic data to justify reimbursement of prescription medicines by public and private payers. An additional major responsibility was developing strategies to respond effectively to the broad array of potential health reform initiatives in the United States. Mark is on the clinical faculty of the Mount Sinai Hospital and School of Medicine (NYC), is a current member of the US Pharmacopoeia Safe Medication Use Expert Committee. He also served on the US Pharmacopoeia Medicare Model Guidelines Expert Committee which, by Congressional statute, determined the categories and classes of medicines reimbursable under the Medicare Part D drug benefit. In addition to his MD (New York University) and undergraduate (Brown) degrees, Mark holds an MPH degree in Health Policy and Management (Columbia).

For more information about Target Health or any of its software tools for paperless clinical trials, please contact Dr. Jules T. Mitchel or Ms. Joyce Hays. Target Health’s software tools are designed to partner with both CROs and Sponsors. Please visit the Target Health Website

Comments

Leave a Reply

You must be logged in to post a comment.